ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has reported EBT Margin for 3 consecutive years, with 45761.31% the latest figure, recorded in Q1 2018.

• On a quarterly basis, EBT Margin changed N/A year-over-year to 45761.31% in Q1 2018; TTM through Dec 2018 was 158669.6%, a 15714041.0% decrease from a year earlier, with the FY2018 full-year figure at 158669.6%, down 15714041.0% from the prior year.
• EBT Margin was 45761.31% for Q1 2018 at ENDRA Life Sciences, down from 33498.39% in the prior quarter.
• Over five years, EBT Margin peaked at 133.61% in Q4 2016 and troughed at 45761.31% in Q1 2018.
• A 3-year average of 16437.67% and a median of 2478.35% in 2017 frame the typical range for EBT Margin.
• The widest YoY moves for EBT Margin: up 3336478 bps in 2017, down 3336478 bps in 2017.
• Over 3 years, EBT Margin stood at 133.61% in 2016, then plunged by 24971 bps to 33498.39% in 2017, then plunged by 37 bps to 45761.31% in 2018.
• The last three EBT Margin figures came in at 45761.31% (Q1 2018), 33498.39% (Q4 2017), and 316.69% (Q3 2017), per Business Quant data.